You can watch XBIOW and buy or sell other stocks, options, and ETFs commission-free!
Xenetic Biosciences, Inc. engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA. The listed name for XBIOW is Xenetic Biosciences, Inc. Warrants.
Jeffrey F. Eisenberg
52 Week High
52 Week Low